grant

Health Outcomes & Behavior

Organization H. LEE MOFFITT CANCER CTR & RES INSTLocation TAMPA, UNITED STATESPosted 18 Feb 1998Deadline 31 Jan 2027
NIHUS FederalResearch GrantFY202521+ years oldAIDS VirusAccess to CareAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAddressAdoptionAdultAdult HumanAffectAreaAutomobile DrivingAwarenessBehaviorBehavioralBlack PopulationsBlack groupBlack individualBlack peopleBlacksCCSGCRC screeningCancer BurdenCancer Center Support GrantCancer ControlCancer Control ScienceCancer DetectionCancer SurvivorshipCancer TreatmentCancersCare GiversCaregiversCaringCatchment AreaClientClinicalCollaborationsCommunitiesCongressesCountyDetectionDevelopmentDiagnosisDirect CostsDistressEvidence based interventionFamiliar Malignant NeoplasmFamilyFederally Qualified Health CenterFoodFosteringFundingGenetic CounselingGoalsGrantGroups at riskGuidelinesHIVHPV preventionHealthHealth Care SystemsHealth PolicyHealth Services AccessibilityHealth behaviorHealth behavior and outcomesHereditary CancerHereditary Malignant NeoplasmHispanic PopulationsHispanic groupHispanic individualHispanic peopleHispanicsHumanHuman Immunodeficiency VirusesHuman papillomavirus preventionIndividualInstitutionInternationalInterventionIntervention StudiesLAV-HTLV-IIILaboratory StudyLong-Term EffectsLong-Term SurvivorshipLymphadenopathy-Associated VirusMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant TumorModern ManMorbidityMorbidity - disease rateNational Cancer BurdenNational Institutes of HealthObservation researchObservation studyObservational StudyObservational researchOutcomePatient CarePatient Care DeliveryPatient Outcomes AssessmentsPatient Reported MeasuresPatient Reported OutcomesPatientsPeer ReviewPeople at riskPersonsPersons at riskPoliciesPopulationPopulations at RiskPractice GuidelinesPrevalencePreventionPrevention MeasuresProcessProviderPublic HealthPublishingQOLQOL improvementQualifyingQuality of lifeRandomized, Controlled TrialsRecommendationResearchResearch ActivityResearch InstituteResearch PriorityRisk FactorsScreening for cancerServicesSiteSocial NetworkSystemTobacco ConsumptionTobacco useTobacco-Related CarcinomaTranslational ResearchTranslational ScienceTranslationsUnderserved PopulationUnited NationsUnited States National Institutes of HealthVirus-HIVVulnerable PopulationsWorkaccess to health servicesaccess to servicesaccess to treatmentaccessibility to health servicesactive methodactive techniqueactive treatmentaddictionaddictive disorderadulthoodanti-cancer therapyavailability of servicesbiobehaviorbiobehavioralcancer carecancer preventioncancer survivor carecancer survivorship carecancer therapycancer-directed therapycare accesscare deliverycare for patientscare of patientscare providerscaring for patientscease smokingclinical careclinical practicecolorectal cancer detectioncolorectal cancer early detectioncolorectal cancer screeningcommunity barriercommunity based organizationscommunity based participatory researchcommunity engagementcommunity led researchcommunity organizationscommunity participatory researchcommunity partnered participatory researchcommunity-level barrierdetect colorectal cancerdevelop therapydevelopmentaldifferences in healthdrivingearly cancer detectionend of lifeend-of-lifeenergy balanceengagement with communitiesevidence baseex-smokerfamilial cancerformer smokergene testinggene-based testinggenetic consultationgenetic testinghealth and care deliveryhealth care deliveryhealth care policyhealth delivery systemshealth differencehealth goalshealth related behaviorhealth service accesshealth services availabilityhealth services deliveryimplementation researchimplementation scienceimprovedimprovements in QOLimprovements in quality of lifeindividualized preventioninnovateinnovationinnovativeintervention developmentintervention researchinterventional researchinterventional studyinterventions researchlow dose computed tomographylow dose computerized tomographylow-dose CTlung cancer early detectionlung cancer screeningmalignancymemberneoplasm/cancernew approachesnovel approachesnovel strategiesnovel strategyparticipatory action researchpersonalized preventionpopulation healthprecision preventionprevent HPVprevent human papillomavirusprogramspsychologicpsychologicalpsychosocialquality of life and care for cancer survivorsquality of life for cancer survivorsquality of life improvementquit smokingrandomized control trialreduce tobacco usereduction in tobacco userural dwellersrural residentscreeningscreening cancer patientsscreeningsservice availabilityside effectsmoking cessationstop smokingsurvivorshipsymptomatologytargeted drug therapytargeted drug treatmentstargeted therapeutictargeted therapeutic agentstargeted therapytargeted treatmenttherapy developmenttobacco product usetobacco use reductiontobacco-induced cancertobacco-related cancertranslationtranslation researchtranslational investigationtreatment accesstreatment developmentunder served groupunder served individualunder served peopleunder served populationunderserved groupunderserved individualunderserved peopleuptakevulnerable groupvulnerable individualvulnerable people
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY
HEALTH OUTCOMES & BEHAVIOR PROGRAM

The overarching goal of the Health Outcomes & Behavior (HOB) Program is to improve cancer outcomes by understanding and intervening on the behavior of individuals, social networks, healthcare systems, and communities. Supporting this goal, HOB research activities are organized into three Specific Aims:

Aim 1: To reduce the burden of tobacco-related cancers by understanding mechanisms of addiction, and by developing and implementing evidence-based interventions to reduce tobacco use across populations.

Aim 2: To improve utilization of cancer prevention and detection services through the development and implementation of multi-level interventions targeting patient-, provider-, systems-, and community-level barriers and facilitators.

Aim 3: To improve the quality of survivorship through innovative research that identifies and intervenes on the short- and long-term physical and psychological effects of cancer and its treatment.

The impact of research in the three Aims is manifest through two cross-cutting themes that seek to: 1) improve healthcare delivery for cancer prevention and treatment; and 2) reduce differences cancer-related health outcomes across populations.

HOB is comprised of 28 Members from 8 different academic departments. Since 2016, 554 cancer-related articles were published, with 30% representing intra-programmatic collaborations and 25% representing inter-programmatic collaborations. Notably, since the last renewal, the number of NIH R01 grants with HOB PIs has doubled from 5 to 10, including 9 from NCI. HOB Members hold a total of 14 qualifying R01/equivalent grants. Grant funding is $5.7 million in direct costs, of which $4.5 million is peer-reviewed, including 57% from NCI. HOB is also strongly committed to multi-institute research and has also increased multi-site studies from 10 to 17.

HOB Program Members conduct policy-changing observational and intervention research on the major cancers that affect the catchment area and vulnerable populations with respect to prevention, screening, quality of life, and cancer care delivery. Additionally, HOB Members conduct community-based participatory research in concert with organizations in the catchment area with the goal of reducing differences in health outcomes through multi-level practice changes. Synergistic goals over the next five years include expanding partnerships with community cancer care providers and other health centers in our catchment area, expanding cancer care delivery research and implementation science, and increasing the HOB research portfolio in energy balance for cancer prevention and control. By collaborating with colleagues from other Programs and institutions, HOB Members conduct translational research that is driving scientific discovery, establishing public health policies, and transforming patient care delivery, practice, and quality of life.

Grant Number: 5P30CA076292-27
NIH Institute/Center: NIH

Principal Investigator: THOMAS BRANDON

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →